Reference no: EM133854140
Assignment:
A variety of factors related to the cancer and its treatment are likely to impact on the development of depression and anxiety, including the type of cancer, stage and prognosis. Cancer treatments including immunotherapy and chemotherapy may induce depression through particular biological mechanisms, such as inflammatory pathways, and some medications used to treat chemotherapy-induced nausea can reduce dopaminergic transmission, which is implicated in the development of depressive symptoms [16]. The use of steroids in cancer treatment can induce depression [17], and androgen deprivation therapy in the treatment of prostate cancer is also associated with increased risk [18]. The physical symptoms of specific cancers can also contribute to depression (e.g. incontinence and sexual dysfunction associated with prostate cancer) [19]. Iatrogenic distress is also commonly reported amongst patients, which could increase the risk of experiencing later problems with depression and anxiety, including post-traumatic stress disorder [20]. This is often related to a combination of poor communication, a lack of consideration of psychological concerns and disjointed care
1. Please give examples of red meat, white meat and lean meat.
2. What is lean body weight and how does it differ from routine measurement?
3. Is the combination of drugs sibutramine and orlistat more effective in reducing obesity than using these on their own?
4. Why does vitamin B12 deficiency cause glossitis?
5. Is a dosage of 2.5 mg/day of methyltestosterone, as a component in some multivitamin formulae, safe in the long-term?
6. What is the effect of sodium/potassium imbalance on the microminerals?
7. What is the role of fluoride in healing?
8. In K&C 7e (Box 5.6, p. 239) it states 'Do not drink [alcohol] during the daytime'. Please explain why this is not recommended.
9. Could you please tell me about the aetiology of 'refeeding syndrome'?
10. What is the Atkin's diet?